Stroke is the leading cause of death and disability in adults in China, and acute ischemic stroke (AIS) accounts for about 70 ...

New research published this month shows the key role quality improvement programs play in ensuring hospitals can adequately fight one of the biggest public health threats facing our country: stroke.

New research published this month shows the key role quality improvement programs play in ensuring hospitals can adequately ...

A retrospective look at Get With The Guidelines® – Stroke registry data from 2003 to 2022 finds substantial and sustained ...

A study uncovers IL-1β signaling in cardiac fibrosis, highlighting distinct fibroblast populations and promising ...

What you need to know Intravenous thrombolytics, including the recombinant tissue plasminogen activators alteplase or ...

Atrial fibrillation is a key risk factor for ischaemic stroke. Furthermore, patients with atrial fibrillation and stroke tend ...

Early onset coronary artery disease (CAD) in individuals under 45 years old presents unique challenges, with prevalence rates of 1-2% generally, and as high as 5-10% among South Asian populations.

A study was conducted to determine if stroke revascularization therapies are associated with risk for poststroke epilepsy.

HealthDay News — For patients with acute ischemic stroke (AIS), tenecteplase (TNK) has improved functional outcome and reduced disability and similar safety to alteplase (tissue plasminogen activator ...

Dual antiplatelet therapy with clopidogrel and aspirin can benefit patients with mild ischemic stroke when initiated up to 72 hours after symptom onset.

Tenecteplase was shown to be superior to alteplase for acute ischemic stroke, with a greater chance of excellent recovery and ...